The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06474884, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Xuanwu Hospital, Beijing
- Trial code
- NCT06474884
- Record updated
- 10 December 2024
- Original description
The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.Read full original descriptionShow less
A Single-center, Prospective, Cohort Study of the Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield Stent Implantation for Intracranial Aneurysms
The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.
Inclusion: Patients with unruptured intracranial aneurysms who received the intracranial Pipeline Flex with Shield stent; Vascular conditions:; There was no obvious calcification and stenosis of the parent artery. 2) The curvature of the bearing artery is minimal. 3) The parent artery diameter ≥2.5mm; 3.According to the committee's assessment, only one Pipeline flex with shield is needed for aneurysm treatment; 4.Before the stent implantation procedure, standard dual antiplatelet therapy should be administered for at least 3 days; 5.Patients with an Modified Rankin Scale(mRS) score of less than 2 on the day of registration; 6.The operation was successful, and immediate postoperative angiography indicated good wall apposition.
Exclusion: Patients with recurrent aneurysms after interventional treatment or surgical clipping; The patient after stent placement surgery; The patient had no history of stroke or aneurysm rupture in the last 3 months; Known history of allergy to clopidogrel or heparin; Abnormal platelet function, or platelet count < 100,000 cells/mm³; Aneurysms can have irregular shapes, such as fusiform, blister-type, or dissecting aneurysms.